Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine Regimens in Adult Participants Hospitalized With Respiratory Syncytial Virus
Clinical trial NCT02935673 · TERMINATED
Trial details
- NCT number
- NCT02935673
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-25
- Primary completion
- 2018-07-17
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.